Fingerprints of Chalcogen Bonding Revealed Through 77Se-NMR

29 January 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

77Se-NMR is used to characterise several chalcogen bonded complexes of derivatives of the organoselenium drug ebselen, exploring a range of electron demand. NMR titration experiments support the intuitive understanding that chalcogen bond donors bearing more electron withdrawing substituents give rise stronger chalcogen bonds. The chemical shift of the selenium nucleus is also shown to move upfield as it participates in a chalcogen bond. Solid-state NMR is used to explore chalcogen bonding in co-crystals. Due to the lack of molecular reorientation on the NMR timescale in the solid state, the shape of the chemical shift tensor can be determined using this technique. A range of co-crystals are shown to have extremely large chemical shift anisotropy, which suggests a strongly anisotropic electron density distribution around the selenium atom. A single crystal NMR experiment was conducted using one of the co-crystals, affording the absolute orientation of the chemical shift tensor within the crystal. This showed that the selenium nucleus is strongly shielded in the direction of the chalcogen bond, and strongly deshielded in the perpendicular direction, consistent with the presence of a second sigma-hole which is not participating in a chalcogen bond.

Keywords

Chalcogen bonding
SSNMR
Chemical shift tensor

Supplementary materials

Title
Description
Actions
Title
Supplementary information for “Fingerprints of Chalcogen Bonding Revealed Through 77Se-NMR"
Description
Supplementary information for “Fingerprints of Chalcogen Bonding Revealed Through 77Se-NMR"
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.